Federated Hermes, Inc. Synlogic, Inc. Transaction History

Federated Hermes, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$1.63 - $2.55 $378 - $591	-232 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.27 - $3.0 $276 - $366	-122 Reduced 34.46%	232 $1,000
Q3 2021 Nov 15, 2021	SELL	$2.45 - $4.1 $1,568 - $2,624	-640 Reduced 64.39%	354 $1,000
Q2 2021 Aug 16, 2021	SELL	$3.0 - $4.39 $378 - $553	-126 Reduced 11.25%	994 $4,000
Q1 2021 May 13, 2021	BUY	$2.2 - $5.05 $2,464 - $5,656	1,120 New	1,120 $4,000

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $105M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.